Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
Journal of Cell Science|August 27, 2009
Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cellsMei-Ren Pan, Tsung-Ming Chang, Hui-Chiu Chang, et al.Journal of Personalized Medicine|March 25, 2022
Correction: Kao et al. RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655Chieh-Ni Kao, Sin-Hua Moi, Ming-Feng Hou, et al.The Journal of Biological Chemistry|January 6, 2012
Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatmentMei-Ren Pan, Hui-Ju Hsieh, Hui Dai, et al.Oncotarget|August 18, 2016
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancerMei-Ren Pan, Ming-Chuan Hsu, Chi-Wen Luo, et al.Anticancer Research|October 28, 2020
High Expression of UBE2B as a Poor Prognosis Factor in Patients With Rectal Cancer Following ChemoradiotherapyWei-Lun Huang, Chi-Wen Luo, Chia-Lin Chou, et al.Cancer Genomics & Proteomics|October 27, 2023
SUV39H1 Expression as a Guideline for Omitting Radiotherapy in Lymph Node-positive Triple-negative Breast Cancer PatientsWei-Lun Huang, Chi-Wen Luo, Huei-Shan Lin, et al.International Journal of Molecular Sciences|March 6, 2021
Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell CancerHui-Ching Wang, Leong-Perng Chan, Chun-Chieh Wu, et al.Anticancer Research|April 28, 2026
Ubiquitin Ligase RNF149 Promotes Head and Neck Cancer Growth via Downregulation of CDKN2CYu-Hsuan Hung, Min-Hong Wang, Li-Tzong Chen, et al.Cancers|December 23, 2018
Protein Arginine Methyltransferase 3 Enhances Chemoresistance in Pancreatic Cancer by Methylating hnRNPA1 to Increase ABCG2 ExpressionMing-Chuan Hsu, Mei-Ren Pan, Pei-Yi Chu, et al.American Journal of Cancer Research|January 8, 2021
The CDK6-c-Jun-Sp1-MMP-2 axis as a biomarker and therapeutic target for triple-negative breast cancerChi-Wen Luo, Ming-Feng Hou, Chia-Wei Huang, et al.Pageof 8